DE68914886T2 - Mittel zur Behandlung von Raynaud's Krankheit. - Google Patents

Mittel zur Behandlung von Raynaud's Krankheit.

Info

Publication number
DE68914886T2
DE68914886T2 DE68914886T DE68914886T DE68914886T2 DE 68914886 T2 DE68914886 T2 DE 68914886T2 DE 68914886 T DE68914886 T DE 68914886T DE 68914886 T DE68914886 T DE 68914886T DE 68914886 T2 DE68914886 T2 DE 68914886T2
Authority
DE
Germany
Prior art keywords
raynaud
disease
agent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68914886T
Other languages
English (en)
Other versions
DE68914886D1 (de
Inventor
Shinichiro C O Daiichi Ashida
Kyoko C O Daiichi Seiya Sakuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE68914886D1 publication Critical patent/DE68914886D1/de
Application granted granted Critical
Publication of DE68914886T2 publication Critical patent/DE68914886T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE68914886T 1988-06-17 1989-06-16 Mittel zur Behandlung von Raynaud's Krankheit. Expired - Fee Related DE68914886T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14944588 1988-06-17

Publications (2)

Publication Number Publication Date
DE68914886D1 DE68914886D1 (de) 1994-06-01
DE68914886T2 true DE68914886T2 (de) 1994-08-11

Family

ID=15475275

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68914886T Expired - Fee Related DE68914886T2 (de) 1988-06-17 1989-06-16 Mittel zur Behandlung von Raynaud's Krankheit.

Country Status (7)

Country Link
EP (1) EP0346929B1 (de)
JP (1) JPH0276814A (de)
KR (1) KR910000148A (de)
AU (1) AU627739B2 (de)
CA (1) CA1332357C (de)
DE (1) DE68914886T2 (de)
ES (1) ES2064382T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2080130A1 (en) * 1990-04-09 1991-10-10 Satoshi Kitamura Remedy for obstructive pulmonary diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191612A (ja) * 1985-02-20 1986-08-26 Dai Ichi Seiyaku Co Ltd 虚血性心疾患用剤

Also Published As

Publication number Publication date
EP0346929B1 (de) 1994-04-27
AU627739B2 (en) 1992-09-03
JPH0276814A (ja) 1990-03-16
DE68914886D1 (de) 1994-06-01
CA1332357C (en) 1994-10-11
ES2064382T3 (es) 1995-02-01
EP0346929A3 (en) 1990-10-31
EP0346929A2 (de) 1989-12-20
KR910000148A (ko) 1991-01-29
AU3648089A (en) 1989-12-21

Similar Documents

Publication Publication Date Title
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE69024039T2 (de) Behandlung von pathologischen zuständen und krankheiten.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69019488D1 (de) Behandlung von Geflügel.
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE69018043T3 (de) Behandlung von Geflügel.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.
DE68905479T2 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee